NDT Pharmaceuticals IncOTC Pink - Current Information:NDTP
- LAST PRICE0.3300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.2600/ 25
- Ask / Lots0.3749/ 25
- Open / Previous Close0.0000 / 0.3300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
NDT Pharmaceuticals Inc | 52.8M | 0.0x | --- |
Odonate Inc | 46.5M | -1,170.1x | --- |
Bright Green Corp | 41.5M | -4.1x | --- |
Spectral Medical Inc | 89.0M | -8.0x | --- |
Global Pharmatech Inc | 59.3M | -1.6x | --- |
Vyne Therapeutics Inc | 32.4M | -0.3x | --- |
Company Information
NDT Pharmaceuticals, Inc. is a Canada-based company, which is focused on developing nutraceutical and pharmaceutical products utilizing intellectual property. The Company has acquired all rights under a Sponsored Research Agreement with the University of Pennsylvania, including rights to use the University's Nanoscale Particle Complex (NPC) technology. The intellectual property includes a versatile and widely applicable biotechnology asset base, including the Nanoscale Particle Complex (NPC) technology, which represents phospholipid-based nano-encapsulation delivery systems that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth. The NPC technology also incorporates a potent active ingredient that stimulates repair of damaged cell tissue branded by the Company as Cell Armor.
Contact Information
- Headquarters
- Suite 809-4438 West 10Th AvenueVANCOUVER, BC, Canada V6R 4R8
- Phone
- 604-689-4088
- Fax
- ---
Executives
- Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer, Director
- Kent Carasquero
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $52.8M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 160.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | --- |
Book Value | $1.25 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
